OpenAI Collaborates on GPT-Rosalind Brain Research
OpenAI presented GPT-Rosalind in work with PerturbAI and Scripps Research on brain research and neurodegenerative diseases. OpenAI says the system helps scientists identify new leads for understanding and treating these diseases, but the supplied report provides no supporting research details or independent validation.
The collaboration connects GPT-Rosalind with brain research focused on neurodegenerative diseases, while its claimed scientific benefits remain an OpenAI assertion without independent validation in the supplied report.
GPT-Rosalind for new leads for understanding and treating neurodegenerative diseases: https://twitter.com/OpenAI/status/2123899406550528422
@OpenAI: How AI is helping scientists uncover new leads for understanding and treating neurodegenerative diseases—and the brain research behind our collaboration with @perturbai_tx and @scrippsresearch: https://x.com/OpenAI/status/2123899406550528422/video/1 https://twitter.com/OpenAI/status/2112899854569762936 https://x.com/OpenAI/status/2123899406550528422